These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26456498)

  • 1. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.
    Faverzani JL; Steinmetz A; Deon M; Marchetti DP; Guerreiro G; Sitta A; de Moura Coelho D; Lopes FF; Nascimento LVM; Steffens L; Henn JG; Ferro MB; Brito VB; Wajner M; Moura DJ; Vargas CR
    Metab Brain Dis; 2021 Oct; 36(7):1957-1968. PubMed ID: 34216350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cytokine levels induced by high phenylalanine concentrations in late diagnosis PKU patients compared to early diagnosis: Anti-inflammatory effect of L-carnitine.
    Faverzani JL; Hammerschmidt TG; Mescka CP; Guerreiro G; Lopes FF; Delgado CA; de Moura Coelho D; Sitta A; Deon M; Wajner M; Vargas CR
    Cell Biochem Funct; 2023 Jun; 41(4):490-500. PubMed ID: 37170672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation.
    Jacques CE; Donida B; Mescka CP; Rodrigues DG; Marchetti DP; Bitencourt FH; Burin MG; de Souza CF; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2016 Sep; 1862(9):1608-16. PubMed ID: 27251652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
    Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of L-carnitine on Phenylalanine-induced DNA damage.
    Deon M; Landgraf SS; Lamberty JF; Moura DJ; Saffi J; Wajner M; Vargas CR
    Metab Brain Dis; 2015 Aug; 30(4):925-33. PubMed ID: 25600689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.
    Fernandes CG; Leipnitz G; Seminotti B; Amaral AU; Zanatta A; Vargas CR; Dutra Filho CS; Wajner M
    Cell Mol Neurobiol; 2010 Mar; 30(2):317-26. PubMed ID: 19774456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
    Douglas TD; Jinnah HA; Bernhard D; Singh RH
    Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria.
    Sanayama Y; Nagasaka H; Takayanagi M; Ohura T; Sakamoto O; Ito T; Ishige-Wada M; Usui H; Yoshino M; Ohtake A; Yorifuji T; Tsukahara H; Hirayama S; Miida T; Fukui M; Okano Y
    Mol Genet Metab; 2011 Jul; 103(3):220-5. PubMed ID: 21514861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of urinary tryptophan metabolites in relation to the phenylalanine content of semi-synthetic diets in a patient with phenylketonuria.
    Byrd DJ; Kochen W; Schürrle L; Trefz FK
    Acta Vitaminol Enzymol; 1975; 29(1-6):55-61. PubMed ID: 1244125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
    Bortoluzzi VT; Brust L; Preissler T; de Franceschi ID; Wannmacher CMD
    Metab Brain Dis; 2019 Dec; 34(6):1649-1660. PubMed ID: 31352540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
    Biancini GB; Vanzin CS; Rodrigues DB; Deon M; Ribas GS; Barschak AG; Manfredini V; Netto CB; Jardim LB; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2012 Feb; 1822(2):226-32. PubMed ID: 22085605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.